Liver & Intestine Transplant Perspective

• The Medication That Patients Were Itching to Try Dr William Balistreri comments on the considerable promise of novel therapies for intractable cholestatic pruritus.
  Medscape Gastroenterology, May 23, 2022
• Alarming Global Rise in Pediatric Hepatitis: Expert Q&A Pediatric hepatologist Dr William Balistreri shares his insights on the mysterious, possibly adenovirus-related outbreak.
  Medscape Gastroenterology, May 05, 2022
• ACG Offers Guidelines for Acute-on-Chronic Liver Failure A conversation with the lead author behind the recently published recommendations on how to manage this major cause of mortality in patients with chronic liver disease.
  Medscape Gastroenterology, March 07, 2022
• Organ Transplantation: Unvaccinated Need Not Apply Outrage over the denial of transplant organs to the unvaccinated is an opportunity to educate people on the complexities of organ allocation, writes Melissa Walton-Shirley, channeling her inner Ted Lasso.
  theheart.org on Medscape, February 10, 2022
• Treating NAFLD by Defeating Obesity: What Are the Best Options? Bariatric surgery is often the treatment of last resort, but considering it earlier may be just what patients with fatty liver disease need.
  Medscape Gastroenterology, January 21, 2022
• The Year in Gastroenterology Literature: 11 Must-Reads New guidelines, expert reviews, and clinical studies offered plenty of practice-changing possibilities in 2021, according to Dr David Johnson.
  Medscape Gastroenterology, December 23, 2021
• Transthyretin Amyloid and New Treatment Options   A Mayo Clinic panel comprising Drs Martha Grogan, Julie Rosenthal, and Melissa Lyle discuss new and investigational treatment options for transthyretin amyloid.
  Mayo Clinic, December 06, 2021
• AASLD 2021 Read clinically focused news coverage of key developments from AASLD 2021
  Medscape Gastroenterology, November 15, 2021
• COVID-19 and Liver Disease: Answering the Key Questions A trove of new data is bringing clarity regarding the impact of COVID-19 on patients with liver disease, although there's still much to learn.
  Medscape Gastroenterology, August 18, 2021
• ILC 2021 Read clinically focused news coverage of key developments from ILC 2021
  Medscape Gastroenterology, June 23, 2021
• The Alcohol Pandemic: Are We Ready for What's Next? Drinking and obesity are on the rise, creating a perfect storm for liver disorders in our patients.
  Medscape Gastroenterology, May 25, 2021
• The Mediterranean Diet Gets a Green Boost Modifying the Mediterranean diet with additional green plant-based proteins/polyphenols results in intriguing benefits.
  Medscape Gastroenterology, May 18, 2021
• Counseling Adolescents With Obesity: Lead With the Evidence Dr William F. Balistreri comments on the data surrounding the consequences of obesity in young people and the most effective interventions.
  Medscape Gastroenterology, April 23, 2021
• Lessons Learned During COVID-19 Will Help Us Better Treat HCV In figuring out how to practice during a pandemic, we may have also learned new skills for monitoring and treating patients with HCV, says Dr William Balistreri.
  Medscape Gastroenterology, April 21, 2021
• Liver Cancer Rates Are Rising; So Is Optimism Around Its Treatment Dr Nancy Reau shares the promising data leading her to believe that the trends around liver cancer can soon be reversed.
  Medscape Gastroenterology, November 20, 2020
• Vanquishing Hepatitis C: A Remarkable Success Story A look back at one of the singular achievements in medical research of the past 25 years, and what improvements are still to come.
  Medscape Gastroenterology, November 17, 2020
• AASLD 2020 Read clinically focused news coverage of key developments from AASLD 2020
  Medscape Gastroenterology, November 13, 2020
• Why Biliary Atresia Demands Our Respect Dr William Balistreri explains how interceding quickly can help limit the devastating effects of this rare disease in infants.
  Medscape Gastroenterology, August 19, 2020
• Obeticholic Acid for NASH: Revolution or Just a Ripple? With FDA approval likely by year's end, Drs Jason Kramer and Nancy Reau consider what obeticholic acid may mean for this increasingly prevalent disease.
  Medscape Gastroenterology, July 10, 2020
• Treating Liver Disease During COVID-19: New Recommendations Guidance from the AASLD comes with a disclaimer but still offers valuable insights to clinicians, says Dr William F. Balistreri.
  Medscape Gastroenterology, May 14, 2020